Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Common Stock | Purchase | $6.08M | +42.1K | +0.76% | $144.52 | 5.56M | Sep 1, 2022 | Direct | F1, F2 |
transaction | MEDP | Common Stock | Purchase | $7.06M | +48.7K | +0.88% | $144.98 | 5.6M | Sep 2, 2022 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2022, and amended on May 3, 2022. |
F2 | The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $143.20 to $145.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
F3 | The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $144.70 to $145.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |